Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Melanoma-associated antigen 3 (Antigen MZ2-D) (Cancer/testis antigen 1.3) (CT1.3) (MAGE-3 antigen)

 MAGA3_HUMAN             Reviewed;         314 AA.
P43357; Q6FHI6;
01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
01-NOV-1995, sequence version 1.
25-OCT-2017, entry version 141.
RecName: Full=Melanoma-associated antigen 3;
AltName: Full=Antigen MZ2-D;
AltName: Full=Cancer/testis antigen 1.3;
Short=CT1.3;
AltName: Full=MAGE-3 antigen;
Name=MAGEA3; Synonyms=MAGE3;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND MUTAGENESIS.
TISSUE=Blood;
PubMed=8113684; DOI=10.1084/jem.179.3.921;
Gaugler B., van den Eynde B., van der Bruggen P., Romero P.,
Gaforio J.J., De Plaen E., Lethe B.G., Brasseur F., Boon T.;
"Human gene MAGE-3 codes for an antigen recognized on a melanoma by
autologous cytolytic T lymphocytes.";
J. Exp. Med. 179:921-930(1994).
[2]
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Skin;
PubMed=8037761; DOI=10.1006/bbrc.1994.1963;
Ding M., Beck R.J., Keller C.J., Fenton R.G.;
"Cloning and analysis of MAGE-1-related genes.";
Biochem. Biophys. Res. Commun. 202:549-555(1994).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
"Cloning of human full open reading frames in Gateway(TM) system entry
vector (pDONR201).";
Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Testis;
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=10854409; DOI=10.1101/gr.10.6.758;
Mallon A.-M., Platzer M., Bate R., Gloeckner G., Botcherby M.R.M.,
Nordsiek G., Strivens M.A., Kioschis P., Dangel A., Cunningham D.,
Straw R.N.A., Weston P., Gilbert M., Fernando S., Goodall K.,
Hunter G., Greystrong J.S., Clarke D., Kimberley C., Goerdes M.,
Blechschmidt K., Rump A., Hinzmann B., Mundy C.R., Miller W.,
Poustka A., Herman G.E., Rhodes M., Denny P., Rosenthal A.,
Brown S.D.M.;
"Comparative genome sequence analysis of the Bpa/Str region in mouse
and man.";
Genome Res. 10:758-775(2000).
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=15772651; DOI=10.1038/nature03440;
Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
"The DNA sequence of the human X chromosome.";
Nature 434:325-337(2005).
[7]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Bone marrow, Lung, Prostate, and Skin;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[8]
INTERACTION WITH TRIM28.
PubMed=17942928; DOI=10.1158/0008-5472.CAN-07-1478;
Yang B., O'Herrin S.M., Wu J., Reagan-Shaw S., Ma Y., Bhat K.M.,
Gravekamp C., Setaluri V., Peters N., Hoffmann F.M., Peng H.,
Ivanov A.V., Simpson A.J., Longley B.J.;
"MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and
suppress p53-dependent apoptosis in MAGE-positive cell lines.";
Cancer Res. 67:9954-9962(2007).
[9]
FUNCTION, AND INTERACTION WITH TRIM28.
PubMed=20864041; DOI=10.1016/j.molcel.2010.08.029;
Doyle J.M., Gao J., Wang J., Yang M., Potts P.R.;
"MAGE-RING protein complexes comprise a family of E3 ubiquitin
ligases.";
Mol. Cell 39:963-974(2010).
[10]
X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 271-279 IN COMPLEX WITH HLA
CLASS I HISTOCOMPATIBILITY COMPLEX.
Orth P., Alings C., Saenger W., Ziegler A.;
"Human class I histocompatibility antigen (HLA-A complex with a
nonameric peptide from melanoma-associated antigen 3 (residues 271-
279).";
Submitted (FEB-2009) to the PDB data bank.
-!- FUNCTION: Proposed to enhance ubiquitin ligase activity of RING-
type zinc finger-containing E3 ubiquitin-protein ligases. May
enhance ubiquitin ligase activity of TRIM28 and stimulate p53/TP53
ubiquitination by TRIM28. Proposed to act through recruitment
and/or stabilization of the Ubl-conjugating enzyme (E2) at the
E3:substrate complex. May play a role in embryonal development and
tumor transformation or aspects of tumor progression. In vitro
promotes cell viability in melanoma cell lines. Antigen recognized
on a melanoma by autologous cytolytic T-lymphocytes.
{ECO:0000269|PubMed:20864041}.
-!- SUBUNIT: Interacts with TRIM28. {ECO:0000269|PubMed:17942928,
ECO:0000269|PubMed:20864041, ECO:0000269|Ref.10}.
-!- INTERACTION:
Q13263:TRIM28; NbExp=3; IntAct=EBI-5651459, EBI-78139;
-!- TISSUE SPECIFICITY: Expressed in many tumors of several types,
such as melanoma, head and neck squamous cell carcinoma, lung
carcinoma and breast carcinoma, but not in normal tissues except
for testes and placenta. Never expressed in kidney tumors,
Leukemias and lymphomas.
-!- CAUTION: In vitro experiments by PubMed:17942928 measuring cell
viability in melanoma cell lines used siRNA specific for MAGEA3
and MAGEA6. {ECO:0000305}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; U03735; AAA17446.1; -; Genomic_DNA.
EMBL; U82671; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; CR541767; CAG46566.1; -; mRNA.
EMBL; CR541774; CAG46573.1; -; mRNA.
EMBL; AK292384; BAF85073.1; -; mRNA.
EMBL; BC000340; AAH00340.1; -; mRNA.
EMBL; BC005963; AAH05963.1; -; mRNA.
EMBL; BC011744; AAH11744.1; -; mRNA.
EMBL; BC016803; AAH16803.1; -; mRNA.
EMBL; BC017389; AAH17389.1; -; mRNA.
CCDS; CCDS76045.1; -.
PIR; JC2361; JC2361.
RefSeq; NP_005353.1; NM_005362.3.
RefSeq; XP_005274733.1; XM_005274676.3.
RefSeq; XP_006724881.1; XM_006724818.2.
RefSeq; XP_011529462.1; XM_011531160.2.
RefSeq; XP_011529463.1; XM_011531161.2.
UniGene; Hs.417816; -.
PDB; 1QEW; X-ray; 2.20 A; C=271-279.
PDB; 4V0P; X-ray; 2.07 A; A=104-314.
PDB; 5BRZ; X-ray; 2.62 A; C=168-176.
PDBsum; 1QEW; -.
PDBsum; 4V0P; -.
PDBsum; 5BRZ; -.
ProteinModelPortal; P43357; -.
SMR; P43357; -.
BioGrid; 110276; 5.
DIP; DIP-44886N; -.
IntAct; P43357; 15.
MINT; MINT-1537705; -.
STRING; 9606.ENSP00000359301; -.
iPTMnet; P43357; -.
PhosphoSitePlus; P43357; -.
BioMuta; MAGEA3; -.
DMDM; 1170857; -.
MaxQB; P43357; -.
PaxDb; P43357; -.
PeptideAtlas; P43357; -.
PRIDE; P43357; -.
DNASU; 4102; -.
Ensembl; ENST00000370278; ENSP00000359301; ENSG00000221867.
Ensembl; ENST00000598245; ENSP00000473093; ENSG00000221867.
GeneID; 4102; -.
KEGG; hsa:4102; -.
UCSC; uc033faf.1; human.
CTD; 4102; -.
DisGeNET; 4102; -.
EuPathDB; HostDB:ENSG00000221867.8; -.
GeneCards; MAGEA3; -.
HGNC; HGNC:6801; MAGEA3.
MIM; 300174; gene.
neXtProt; NX_P43357; -.
OpenTargets; ENSG00000221867; -.
PharmGKB; PA30547; -.
eggNOG; KOG4562; Eukaryota.
eggNOG; ENOG4111S70; LUCA.
GeneTree; ENSGT00760000118824; -.
HOGENOM; HOG000231161; -.
HOVERGEN; HBG006315; -.
InParanoid; P43357; -.
OMA; IAREGDC; -.
OrthoDB; EOG091G0TJ0; -.
PhylomeDB; P43357; -.
TreeFam; TF328505; -.
EvolutionaryTrace; P43357; -.
GeneWiki; MAGEA3; -.
GenomeRNAi; 4102; -.
PRO; PR:P43357; -.
Proteomes; UP000005640; Chromosome X.
Bgee; ENSG00000221867; -.
CleanEx; HS_MAGEA3; -.
ExpressionAtlas; P43357; baseline and differential.
Genevisible; P43357; HS.
GO; GO:0005783; C:endoplasmic reticulum; IDA:ParkinsonsUK-UCL.
GO; GO:0089720; F:caspase binding; IDA:ParkinsonsUK-UCL.
GO; GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:ParkinsonsUK-UCL.
GO; GO:1902236; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; IMP:ParkinsonsUK-UCL.
GO; GO:0010955; P:negative regulation of protein processing; IDA:ParkinsonsUK-UCL.
InterPro; IPR021072; MAGE_N.
InterPro; IPR030097; MAGEA3/MAGEA6.
InterPro; IPR002190; MHD_dom.
PANTHER; PTHR11736:SF60; PTHR11736:SF60; 1.
Pfam; PF01454; MAGE; 1.
Pfam; PF12440; MAGE_N; 1.
SMART; SM01373; MAGE; 1.
SMART; SM01392; MAGE_N; 1.
PROSITE; PS50838; MAGE; 1.
1: Evidence at protein level;
3D-structure; Complete proteome; Reference proteome; Tumor antigen;
Ubl conjugation pathway.
CHAIN 1 314 Melanoma-associated antigen 3.
/FTId=PRO_0000156703.
DOMAIN 109 308 MAGE. {ECO:0000255|PROSITE-
ProRule:PRU00127}.
COMPBIAS 40 43 Poly-Ser.
MUTAGEN 170 170 D->A: Abolishes HLA-A1 binding.
{ECO:0000269|PubMed:8113684}.
MUTAGEN 176 176 Y->A: Abolishes HLA-A1 binding.
{ECO:0000269|PubMed:8113684}.
HELIX 104 126 {ECO:0000244|PDB:4V0P}.
HELIX 132 138 {ECO:0000244|PDB:4V0P}.
HELIX 141 146 {ECO:0000244|PDB:4V0P}.
HELIX 147 162 {ECO:0000244|PDB:4V0P}.
STRAND 164 170 {ECO:0000244|PDB:4V0P}.
TURN 171 174 {ECO:0000244|PDB:4V0P}.
STRAND 175 180 {ECO:0000244|PDB:4V0P}.
HELIX 181 183 {ECO:0000244|PDB:4V0P}.
HELIX 199 212 {ECO:0000244|PDB:4V0P}.
HELIX 218 225 {ECO:0000244|PDB:4V0P}.
HELIX 229 231 {ECO:0000244|PDB:4V0P}.
HELIX 242 252 {ECO:0000244|PDB:4V0P}.
STRAND 255 260 {ECO:0000244|PDB:4V0P}.
STRAND 269 273 {ECO:0000244|PDB:4V0P}.
HELIX 275 280 {ECO:0000244|PDB:4V0P}.
HELIX 283 292 {ECO:0000244|PDB:4V0P}.
TURN 293 295 {ECO:0000244|PDB:4V0P}.
HELIX 304 306 {ECO:0000244|PDB:4V0P}.
SEQUENCE 314 AA; 34747 MW; 3F5EB13D1C9946A1 CRC64;
MPLEQRSQHC KPEEGLEARG EALGLVGAQA PATEEQEAAS SSSTLVEVTL GEVPAAESPD
PPQSPQGASS LPTTMNYPLW SQSYEDSSNQ EEEGPSTFPD LESEFQAALS RKVAELVHFL
LLKYRAREPV TKAEMLGSVV GNWQYFFPVI FSKASSSLQL VFGIELMEVD PIGHLYIFAT
CLGLSYDGLL GDNQIMPKAG LLIIVLAIIA REGDCAPEEK IWEELSVLEV FEGREDSILG
DPKKLLTQHF VQENYLEYRQ VPGSDPACYE FLWGPRALVE TSYVKVLHHM VKISGGPHIS
YPPLHEWVLR EGEE


Related products :

Catalog number Product name Quantity
10-663-45604 Melanoma-Associated Antigen 1 (MAGE-1) Human - MAGE-1 antigen; Antigen MZ2-E N_A 0.002 mg
10-663-45604 Melanoma-Associated Antigen 1 (MAGE-1) Human - MAGE-1 antigen; Antigen MZ2-E N_A 0.01 mg
10-663-45604 Melanoma-Associated Antigen 1 (MAGE-1) Human - MAGE-1 antigen; Antigen MZ2-E N_A 0.005 mg
18-003-42857 Melanoma-associated antigen 9 - MAGE-9 antigen Polyclonal 0.1 mg Protein A
20-272-190481 CD146 - Mouse monoclonal [P1H12] to CD146; Melanoma-associated antigen MUC18; Melanoma cell adhesion molecule; Melanoma-associated antigen A32; S-endo 1 endothelial-associated antigen; Cell surface gl 0.05 ml
20-272-191634 CD146 (FITC) - Mouse monoclonal [2Q401] to CD146 (FITC); Melanoma-associated antigen MUC18; Melanoma cell adhesion molecule; Melanoma-associated antigen A32; S-endo 1 endothelial-associated antigen; C 0.025 mg
EIAAB06373 CD63,CD63 antigen,Granulophysin,Homo sapiens,Human,LAMP-3,Lysosomal-associated membrane protein 3,Melanoma-associated antigen ME491,MLA1,Ocular melanoma-associated antigen,OMA81H,Tetraspanin-30,TSPAN3
20-272-190290 CD146 - Mouse monoclonal [OJ79c MUC 18] to CD146; Melanoma-associated antigen MUC18; Melanoma cell adhesion molecule; Melanoma-associated antigen A32; S-endo 1 endothelial-associated antigen; Cell sur 0.1 mg
M-0902 MAGE-1 Antigen (161-169) (human) Melanoma-Associated Antigen 1 (161-169) (human) 98 percent C41H57N11O17 CAS: 144449-86-5 5mg
M-0905 MAGE-3 Antigen (271-279) (human) Melanoma-Associated Antigen 3 (271-279) (human) 98 percent C53H79N13O10 CAS: 160295-81-8 5mg
M-0903 MAGE-3 Antigen (167-176) (human) Melanoma-Associated Antigen 3 (167-176) (human) 98 percent C53H80N12O16S CAS: 178243-46-4 5mg
orb81967 Human Cancer Antigen CA15-3 Antigen Grade protein Cancer Antigen CA15-3 (Breast Cancer) Antigen Grade is a purified reagent for cancer research. For research use only. 50 KU
20-783-71555 MOUSE ANTI HUMAN CD63 FITC - Melanoma 1 antigen; CD63 antigen (Melanoma 1 antigen). isoform CRA_a; CD63 protein Monoclonal 0.1 mg
U1097h CLIA Antigen LB39-AA,Antigen SK29-AA,Homo sapiens,Human,MART1,MART-1,Melanoma antigen recognized by T-cells 1,MLANA,Protein Melan-A 96T
E1097h ELISA kit Antigen LB39-AA,Antigen SK29-AA,Homo sapiens,Human,MART1,MART-1,Melanoma antigen recognized by T-cells 1,MLANA,Protein Melan-A 96T
E1097h ELISA Antigen LB39-AA,Antigen SK29-AA,Homo sapiens,Human,MART1,MART-1,Melanoma antigen recognized by T-cells 1,MLANA,Protein Melan-A 96T
20-783-71554 MOUSE ANTI HUMAN CD63 - Melanoma 1 antigen; CD63 antigen (Melanoma 1 antigen). isoform CRA_a; CD63 protein Monoclonal 0.2 mg
06-271-83317 MAGE-3 Antigen (271-279) Human - MAGE-3 antigen; Antigen MZ2-D 1 mg
15-288-21943 39S ribosomal protein L28. mitochondrial - L28mt; MRP-L28; Melanoma antigen p15; Melanoma-associated antigen recognized by T lymphocytes Polyclonal 0.05 mg
15-288-21943 39S ribosomal protein L28. mitochondrial - L28mt; MRP-L28; Melanoma antigen p15; Melanoma-associated antigen recognized by T lymphocytes Polyclonal 0.1 mg
10-288-21943F 39S ribosomal protein L28. mitochondrial - L28mt; MRP-L28; Melanoma antigen p15; Melanoma-associated antigen recognized by T lymphocytes 0.1 mg
10-288-21943F 39S ribosomal protein L28. mitochondrial - L28mt; MRP-L28; Melanoma antigen p15; Melanoma-associated antigen recognized by T lymphocytes 0.05 mg
EIAAB35258 39S ribosomal protein L28, mitochondrial,Homo sapiens,Human,L28mt,MAAT1,Melanoma antigen p15,Melanoma-associated antigen recognized by T lymphocytes,MRPL28,MRP-L28
orb81974 CEA Antigen (Antigen Grade) protein Carcinoembryonic Antigen (CEA) Antigen Grade is a purified reagent for cancer research. For research use only. 1 mg
18-003-43704 Carcinoembryonic antigen-related cell adhesion molecule 6 - Normal cross-reacting antigen; Non-specific crossreacting antigen; CD66c antigen Polyclonal 0.1 mg Protein A


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur